AKT1 and neoplasm: This action leads to dimerization and autophosphorylation of the ALK kinase domain and thus abnormally activates downstream signaling pathways, such as PI3K/AKT, JAK/STAT3, and RAS/ERK [67, 68], finally acquiring tumor-formation activity [13].